Haleon plc (NYSE:HLN) Shares Sold by Norden Group LLC

Norden Group LLC cut its stake in shares of Haleon plc (NYSE:HLN) by 51.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,578 shares of the company’s stock after selling 25,226 shares during the quarter. Norden Group LLC’s holdings in Haleon were worth $225,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HLN. Procyon Advisors LLC increased its stake in Haleon by 41.3% in the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock valued at $2,196,000 after purchasing an additional 67,329 shares during the last quarter. HighTower Advisors LLC lifted its position in Haleon by 27.2% in the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after purchasing an additional 74,970 shares during the period. Jane Street Group LLC lifted its holdings in Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after acquiring an additional 250,169 shares during the period. Chartwell Investment Partners LLC boosted its holdings in Haleon by 107.8% during the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock worth $5,030,000 after buying an additional 246,594 shares in the last quarter. Finally, Townsquare Capital LLC increased its stake in Haleon by 29.8% in the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after purchasing an additional 109,217 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Performance

Haleon stock opened at $10.68 on Wednesday. The firm has a market capitalization of $48.33 billion, a PE ratio of 31.40, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. The stock’s 50 day moving average price is $9.61 and its 200 day moving average price is $9.84. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a one year low of $7.89 and a one year high of $10.80.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to analysts’ expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, sell-side analysts expect that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. This represents a dividend yield of 1.6%. Haleon’s payout ratio is 58.97%.

Analysts Set New Price Targets

Several research firms have recently commented on HLN. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Haleon presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.